| Dr Alfred F Brem, DO | |
|
1906 Fairview Ave Ste 220, Caldwell, ID 83605-5432 | |
| (208) 459-4667 | |
| (208) 442-6520 |
| Full Name | Dr Alfred F Brem |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1906 Fairview Ave Ste 220, Caldwell, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427187848 | NPI | - | NPPES |
| 269980 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | O-0871 (Idaho) | Primary |
| Entity Name | State Of Alabama Dept Of Mental Health & Mental Retardation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619190998 PECOS PAC ID: 5698684090 Enrollment ID: O20031205000194 |
News Archive
In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.
The US Centers for Disease Control and Prevention (CDC) have now received information on 34 deaths and over 1,600 cases of e-cigarette, or vaping, product use associated lung injury (EVALI), as of October 22, 2019. This means over 120 new cases in just one week. The CDC has run a comprehensive analysis on 29 of the deaths.
In a study to be presented on Feb. 5 in an oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report that cell free DNA analysis is less effective than sequential screening as primary testing for fetal chromosomal abnormalities.
Arable Corporation has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry. Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
› Verified 3 days ago
| Entity Name | Houston County Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619026606 PECOS PAC ID: 9436062296 Enrollment ID: O20040219000209 |
News Archive
In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.
The US Centers for Disease Control and Prevention (CDC) have now received information on 34 deaths and over 1,600 cases of e-cigarette, or vaping, product use associated lung injury (EVALI), as of October 22, 2019. This means over 120 new cases in just one week. The CDC has run a comprehensive analysis on 29 of the deaths.
In a study to be presented on Feb. 5 in an oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report that cell free DNA analysis is less effective than sequential screening as primary testing for fetal chromosomal abnormalities.
Arable Corporation has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry. Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alfred F Brem, DO 1906 Fairview Ave Ste 220, Caldwell, ID 83605-5432 Ph: (208) 459-4667 | Dr Alfred F Brem, DO 1906 Fairview Ave Ste 220, Caldwell, ID 83605-5432 Ph: (208) 459-4667 |
News Archive
In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.
The US Centers for Disease Control and Prevention (CDC) have now received information on 34 deaths and over 1,600 cases of e-cigarette, or vaping, product use associated lung injury (EVALI), as of October 22, 2019. This means over 120 new cases in just one week. The CDC has run a comprehensive analysis on 29 of the deaths.
In a study to be presented on Feb. 5 in an oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, in San Diego, researchers will report that cell free DNA analysis is less effective than sequential screening as primary testing for fetal chromosomal abnormalities.
Arable Corporation has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry. Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies "Biosimilars" for the Treatment of Cancer.
› Verified 3 days ago
Dr. Sandra Lare, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2609 S 10th Ave Ste 102, Caldwell, ID 83605 Phone: 208-454-2766 | |
Wade Harris, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 211 E Logan St, Ste 201, Caldwell, ID 83605 Phone: 208-454-0567 | |
Dr. Paul William Fleenor, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 315 E Elm, Ste 100, Caldwell, ID 83605 Phone: 208-302-7101 Fax: 208-302-7188 | |
Dr. Richard A. Montgomery, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1906 Fairview Ave Ste 220, Caldwell, ID 83605 Phone: 208-795-5072 | |
Colt Kennington, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1906 Fairview Ave Ste 220, Caldwell, ID 83605 Phone: 208-795-5072 | |
Dr. L. Mark Kimsey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 305 E Logan St, Caldwell, ID 83605 Phone: 208-459-2840 Fax: 208-459-3012 |